Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Chickenpox × fludarabine phosphate × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Leukemia, Myeloid, Acute 175 Leukemia, Lymphocytic, Chronic, B-Cell 148 Myelodysplastic Syndromes 142 Leukemia 142 Precursor Cell Lymphoblastic Leukemia-Lymphoma 130 Lymphoma, Non-Hodgkin 113 Lymphoma 105 Hodgkin Disease 96 Multiple Myeloma 95 Lymphoma, Follicular 84 Lymphoma, Mantle-Cell 83 Lymphoma, Large B-Cell, Diffuse 74 Lymphoma, B-Cell, Marginal Zone 68 Myeloproliferative Disorders 67 Burkitt Lymphoma 66 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 62 Leukemia, Myelomonocytic, Chronic 59 Congenital Abnormalities 59 Leukemia, Myeloid, Chronic-Phase 54 Leukemia, Myeloid, Accelerated Phase 54 Recurrence 48 Lymphoma, Large-Cell, Immunoblastic 48 Primary Myelofibrosis 42 Anemia, Refractory, with Excess of Blasts 42 Waldenstrom Macroglobulinemia 41 Blast Crisis 41 Hematologic Neoplasms 39 Neoplasms, Plasma Cell 38 Dendritic Cell Sarcoma, Interdigitating 34 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 32

Interventions

fludarabine phosphate 1 fludarabine 1 Herpes Zoster Vaccine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01953900 2026-01-23

VEGAS

Baylor College of Medicine

Phase 1 Active not recruiting

Chickenpox, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡